| __timestamp | Arrowhead Pharmaceuticals, Inc. | Galapagos NV |
|---|---|---|
| Wednesday, January 1, 2014 | 23138050 | 111110000 |
| Thursday, January 1, 2015 | 57410147 | 129714000 |
| Friday, January 1, 2016 | 41454452 | 139574000 |
| Sunday, January 1, 2017 | 31690298 | 218502000 |
| Monday, January 1, 2018 | 52968505 | 322876000 |
| Tuesday, January 1, 2019 | 81048686 | 427320000 |
| Wednesday, January 1, 2020 | 128874979 | 523667000 |
| Friday, January 1, 2021 | 206342000 | 491707000 |
| Saturday, January 1, 2022 | 297307000 | 515083000 |
| Sunday, January 1, 2023 | 353188000 | 241294000 |
| Monday, January 1, 2024 | 505870000 |
Unleashing the power of data
In the ever-evolving world of biotechnology, research and development (R&D) investments are the lifeblood of innovation. Over the past decade, Arrowhead Pharmaceuticals, Inc. and Galapagos NV have been at the forefront of this transformative journey. From 2014 to 2023, Arrowhead Pharmaceuticals has seen a staggering 2,085% increase in R&D spending, reflecting its commitment to pioneering advancements in RNA interference therapies. Meanwhile, Galapagos NV, a leader in small molecule drug discovery, experienced a 364% rise in R&D investments until 2022, before a notable dip in 2023. This decline could signal strategic shifts or market challenges. As we look to the future, these trends underscore the dynamic nature of biotech innovation, where strategic investments today pave the way for tomorrow's breakthroughs.
Who Prioritizes Innovation? R&D Spending Compared for Alnylam Pharmaceuticals, Inc. and Galapagos NV
Teva Pharmaceutical Industries Limited vs Arrowhead Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Incyte Corporation vs Galapagos NV
Summit Therapeutics Inc. vs Arrowhead Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Exelixis, Inc. and Arrowhead Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Pharming Group N.V. vs Arrowhead Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Galapagos NV
Analyzing R&D Budgets: Verona Pharma plc vs Galapagos NV
Analyzing R&D Budgets: Amneal Pharmaceuticals, Inc. vs Galapagos NV
Comparing Innovation Spending: Apellis Pharmaceuticals, Inc. and Galapagos NV
CRISPR Therapeutics AG vs Galapagos NV: Strategic Focus on R&D Spending
Comparing Innovation Spending: Arrowhead Pharmaceuticals, Inc. and Celldex Therapeutics, Inc.